ADCY5
Adenylate cyclase type 5
Also known as: AC5, ADCY5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95622
- Gene
- ADCY5
- Ensembl
- ENSG00000173175
- Chromosome
- 3
- Canonical length
- 1261 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Vesicles,Plasma membrane,Primary cilium
OverviewNCBI Gene
This gene encodes a member of the membrane-bound adenylyl cyclase enzymes. Adenylyl cyclases mediate G protein-coupled receptor signaling through the synthesis of the second messenger cAMP. Activity of the encoded protein is stimulated by the Gs alpha subunit of G protein-coupled receptors and is inhibited by protein kinase A, calcium and Gi alpha subunits. Single nucleotide polymorphisms in this gene may be associated with low birth weight and type 2 diabetes. Alternatively spliced transcript variants that encode different isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
1261 residues, UniProt reviewed canonical sequence.
>O95622|ADCY5
1 MSGSKSVSPP GYAAQKTAAP APRGGPEHRS AWGEADSRAN GYPHAPGGSA RGSTKKPGGA
61 VTPQQQQRLA SRWRSDDDDD PPLSGDDPLA GGFGFSFRSK SAWQERGGDD CGRGSRRQRR
121 GAASGGSTRA PPAGGGGGSA AAAASAGGTE VRPRSVEVGL EERRGKGRAA DELEAGAVEG
181 GEGSGDGGSS ADSGSGAGPG AVLSLGACCL ALLQIFRSKK FPSDKLERLY QRYFFRLNQS
241 SLTMLMAVLV LVCLVMLAFH AARPPLQLPY LAVLAAAVGV ILIMAVLCNR AAFHQDHMGL
301 ACYALIAVVL AVQVVGLLLP QPRSASEGIW WTVFFIYTIY TLLPVRMRAA VLSGVLLSAL
361 HLAIALRTNA QDQFLLKQLV SNVLIFSCTN IVGVCTHYPA EVSQRQAFQE TRECIQARLH
421 SQRENQQQER LLLSVLPRHV AMEMKADINA KQEDMMFHKI YIQKHDNVSI LFADIEGFTS
481 LASQCTAQEL VMTLNELFAR FDKLAAENHC LRIKILGDCY YCVSGLPEAR ADHAHCCVEM
541 GMDMIEAISL VREVTGVNVN MRVGIHSGRV HCGVLGLRKW QFDVWSNDVT LANHMEAGGK
601 AGRIHITKAT LNYLNGDYEV EPGCGGERNA YLKEHSIETF LILRCTQKRK EEKAMIAKMN
661 RQRTNSIGHN PPHWGAERPF YNHLGGNQVS KEMKRMGFED PKDKNAQESA NPEDEVDEFL
721 GRAIDARSID RLRSEHVRKF LLTFREPDLE KKYSKQVDDR FGAYVACASL VFLFICFVQI
781 TIVPHSIFML SFYLTCSLLL TLVVFVSVIY SCVKLFPSPL QTLSRKIVRS KMNSTLVGVF
841 TITLVFLAAF VNMFTCNSRD LLGCLAQEHN ISASQVNACH VAESAVNYSL GDEQGFCGSP
901 WPNCNFPEYF TYSVLLSLLA CSVFLQISCI GKLVLMLAIE LIYVLIVEVP GVTLFDNADL
961 LVTANAIDFF NNGTSQCPEH ATKVALKVVT PIIISVFVLA LYLHAQQVES TARLDFLWKL
1021 QATEEKEEME ELQAYNRRLL HNILPKDVAA HFLARERRND ELYYQSCECV AVMFASIANF
1081 SEFYVELEAN NEGVECLRLL NEIIADFDEI ISEDRFRQLE KIKTIGSTYM AASGLNDSTY
1141 DKVGKTHIKA LADFAMKLMD QMKYINEHSF NNFQMKIGLN IGPVVAGVIG ARKPQYDIWG
1201 NTVNVASRMD STGVPDRIQV TTDMYQVLAA NTYQLECRGV VKVKGKGEMM TYFLNGGPPL
1261 SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADCY5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 99 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 99 nTPM
- basal ganglia: 74 nTPM
- blood vessel: 61 nTPM
- colon: 35 nTPM
- urinary bladder: 28 nTPM
- cerebral cortex: 26 nTPM
Single-cell type
- cardiomyocytes: 313 nCPM
- peritubular myoid cells: 289 nCPM
- brain inhibitory neurons: 249 nCPM
- adipocytes: 247 nCPM
- thyrotrophs: 223 nCPM
- vascular smooth muscle cells: 180 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- basal ganglia: 196 nTPM
- thalamus: 80 nTPM
- cerebral cortex: 72 nTPM
- white matter: 69 nTPM
- amygdala: 61 nTPM
- medulla oblongata: 58 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ADCY5.
Disease | AllUniProt
Conditions ADCY5 is implicated in, by any mechanism.
- Dyskinesia with orofacial involvement, autosomal recessive (DSKOR) MIM:619647
- Dyskinesia with orofacial involvement, autosomal dominant (DSKOD) MIM:606703
- Neurodevelopmental disorder with hyperkinetic movements and dyskinesia (NEDHYD) MIM:619651
Disease | GeneticClinVar
56 pathogenic / likely-pathogenic of 960 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Dyskinesia with orofacial involvement, autosomal dominant
- Inborn genetic diseases
- Neurodevelopmental disorder with hyperkinetic movements and dyskinesia
- Dyskinesia with orofacial involvement, autosomal recessive
- ADCY5-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.4
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating dopamine receptor signaling pathway
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- adenylate cyclase-inhibiting dopamine receptor signaling pathway
- cAMP biosynthetic process
- cellular response to forskolin
- cellular response to glucagon stimulus
- G protein-coupled adenosine receptor signaling pathway
- intracellular signal transduction
- locomotory behavior
- neuromuscular process controlling balance
- positive regulation of cytosolic calcium ion concentration
- regulation of insulin secretion involved in cellular response to glucose stimulus
- renal water homeostasis
- vascular endothelial cell response to laminar fluid shear stress
Molecular functions
- adenylate cyclase activity
- adenylate cyclase binding
- ATP binding
- metal ion binding
- scaffold protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Adenylyl cyclase class-3/4/guanylyl cyclase
- Adenylate cyclase, conserved domain
- Adenylyl cyclase class-4/guanylyl cyclase, conserved site
- Nucleotide cyclase
- Adenylate cyclase
- Adenylate cyclase, N-terminal
- Adenylate and Guanylate cyclase catalytic domain
- Adenylate cyclase, conserved domain
- Adenylyl cyclase N-terminal extracellular and transmembrane region
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADCY5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADCY5 as an antibody target. Whether an autoantibody or antibody against ADCY5 could matter depends on whether native ADCY5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADCY5 is annotated at the cell surface, where native ADCY5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADCY5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...